Longitude Capital Partners IV, LLC - Sep 30, 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (LXEO)

Filing Manager
Longitude Capital Partners IV, LLC
Reporting Manager
Longitude Capital Partners IV, LLC
Security
Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value)
Symbol
LXEO
Shares outstanding
72.8M shares
Disclosed Ownership
2.77M shares
Ownership
3.8%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 04:17 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Longitude Capital Partners IV, LLC 3.8% 2.77M 0 2.77M /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory
Longitude Venture Partners IV, L.P. 3.8% 2.77M 0 2.77M /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory
Patrick G. Enright 3.8% 2.77M 0 2.77M /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Juliet Tammenoms Bakker 3.8% 2.77M 0 2.77M /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker